08 Sep Vaccine speed must not trump safety
IFPMA has been active in framing the discussion, strongly supporting the rigorous and objective scientific review of safety and efficacy data for the approval of COVID-19 vaccines.
Today, Thomas Cueni DG at IFPMA has had an opinion piece published by The Financial Times: Vaccine speed must not trump safety – Manufacturers know Covid-19 jabs are the wrong arena for currying political favour.